Cargando…

Human Platelets Effectively Kill K‐562 Cells, a Chronic Myelogenic Leukemia Cell Line, in vitro

The cytotoxic effect of isolated human platelets on leukemic cells has been examined in order to investigate the role of platelets in host defense systems. K‐562 cells (a chronic myelogenic leukemia cell line) showed significant change in their morphology and were killed when they were incubated wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sagawa, Terutaka, Kodama, Takeshi, Tominaga, Akio, Okada, Mariko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1990
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918063/ https://www.ncbi.nlm.nih.gov/pubmed/2116392 http://dx.doi.org/10.1111/j.1349-7006.1990.tb02590.x

Ejemplares similares

Tuberostemonine reverses multidrug resistance in chronic myelogenous leukemia cells K562/ADR
por: Wang, Yu Jia, et al.
Publicado: (2017)

Ketoconazole Reverses Imatinib Resistance in Human Chronic Myelogenous Leukemia K562 Cells
por: Prado-Carrillo, Omar, et al.
Publicado: (2022)

Lapatinib Induces Autophagy, Apoptosis and Megakaryocytic Differentiation in Chronic Myelogenous Leukemia K562 Cells
por: Huang, Huey-Lan, et al.
Publicado: (2011)

Prodigiosin induced the caspase-dependent apoptosis in human chronic myelogenous leukemia K562 cell
por: Niakani, Maryam, et al.
Publicado: (2020)

Caveolin-1 contributes to realgar nanoparticle therapy in human chronic myelogenous leukemia K562 cells
por: Shi, Dan, et al.
Publicado: (2016)

Curcumin and Curcumin-Loaded Nanogel Induce Apoptosis Activity in K562 Chronic Myelogenous Leukemia Cells
por: Khatamsaz, Sepideh, et al.
Publicado: (2018)

Efficacy of in vitro treatment of chronic myelogenous leukemia cell line, K562 cells, using 4-hydroperoxycyclophosphamide, alpha-interferon and gamma-interferon.
por: Lee, J. T., et al.
Publicado: (1996)

Inhibition of abl Oncogene Tyrosine Kinase Induces Erythroid Differentiation of Human Myelogenous Leukemia K562 Cells
por: Honma, Yoshio, et al.
Publicado: (1990)

Polyamine analog TBP inhibits proliferation of human K562 chronic myelogenous leukemia cells by induced apoptosis
por: WANG, QING, et al.
Publicado: (2015)

RNF6 promotes chronic myelogenous leukemia cell proliferation and migration by stabilizing vimentin via multiple atypical ubiquitinations
por: Zhang, Hongxia, et al.
Publicado: (2023)

Calcitonin receptor gene expression in K562 chronic myelogenous leukemic cells
por: Mould, Richard, et al.
Publicado: (2003)

Increase in the Level of P‐Glycoprotein mRNA Expression in Multidrug‐resistant K562 Cell Lines Treated with Sodium Butyrate Is Not Accompanied with Erythroid Differentiation
por: Shibata, Hiroyuki, et al.
Publicado: (1990)

Megakaryocytic differentiation in human chronic myelogenous leukemia K562 cells induced by ionizing radiation in combination with phorbol 12-myristate 13-acetate
por: Hirose, Katsumi, et al.
Publicado: (2013)

Effect of bovine dialyzable leukocyte extract on induction of cell differentiation and death in K562 human chronic myelogenous leukemia cells
por: Sierra-Rivera, Crystel A., et al.
Publicado: (2016)

Cytotoxic effects of the compound cis-tetraammine(oxalato)ruthenium(III) dithionate on K-562 human chronic myelogenous leukemia cells
por: Pereira, Flávia de Castro, et al.
Publicado: (2014)

Isorhamnetin 3-O-robinobioside from Nitraria retusa leaves enhance antioxidant and antigenotoxic activity in human chronic myelogenous leukemia cell line K562
por: Boubaker, Jihed, et al.
Publicado: (2012)

Inhibition of the Nrf2-TrxR Axis Sensitizes the Drug-Resistant Chronic Myelogenous Leukemia Cell Line K562/G01 to Imatinib Treatments
por: Xu, Lianrong, et al.
Publicado: (2019)

Rapamycin enhanced the antitumor effects of doxorubicin in myelogenous leukemia K562 cells by downregulating the mTOR/p70S6K pathway
por: Li, Jie, et al.
Publicado: (2019)

Jellyfish extract induces apoptotic cell death through the p38 pathway and cell cycle arrest in chronic myelogenous leukemia K562 cells
por: Ha, Sun-Hyung, et al.
Publicado: (2017)

Secretion of Transforming Growth Factor‐ß by Human Myelogenous Leukemic Cells and Its Possible Role in Proliferation of the Leukemic Cells
por: Komatsu, Keiko, et al.
Publicado: (1989)

C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells
por: Brognara, Eleonora, et al.
Publicado: (2011)

A B‐CELL LINE HAVING CHROMOSOME 14 ABERRATION AT BREAK BAND qll DERIVED FROM AN ADULT T‐CELL LEUKEMIA PATIENT
por: Miyamoto, Kanji, et al.
Publicado: (1988)

Mellitin peptide quantification in seasonally collected crude bee venom and its anticancer effects on myelogenous K562 human leukaemia cell line
por: Obeidat, Maher, et al.
Publicado: (2023)

Wasabi Compound 6-(Methylsulfinyl) Hexyl Isothiocyanate Induces Cell Death with Coexisting Mitotic Arrest and Autophagy in Human Chronic Myelogenous Leukemia K562 Cells
por: Wu, Kun-Ming, et al.
Publicado: (2019)

EXPRESSION OF CR2 (C3d RECEPTOR) ON THE CELL MEMBRANES OF ADULT T CELL LEUKEMIA
por: Kai, Chieko, et al.
Publicado: (1988)

Effects of Reactive Nitrogen Scavengers on NK-Cell-Mediated Killing of K562 Cells
por: Zeng, Yili, et al.
Publicado: (2012)

Atypical Presentation of Chronic Myelogenous Leukemia
por: Updyke, Katelyn Mariko, et al.
Publicado: (2017)

Differentiation of a Ewing's Sarcoma Cell Line towards Neural and Mesenchymal Cell Lineages
por: Kodama, Ken, et al.
Publicado: (1994)

Olive (Olea europaea) Leaf Extract Induces Apoptosis and Monocyte/Macrophage Differentiation in Human Chronic Myelogenous Leukemia K562 Cells: Insight into the Underlying Mechanism
por: Samet, Imen, et al.
Publicado: (2014)

Usnea Acid as Multidrug Resistance (MDR) Reversing Agent against Human Chronic Myelogenous Leukemia K562/ADR Cells via an ROS Dependent Apoptosis
por: Wang, Wenjing, et al.
Publicado: (2019)

Acadesine Kills Chronic Myelogenous Leukemia (CML) Cells through PKC-Dependent Induction of Autophagic Cell Death
por: Robert, Guillaume, et al.
Publicado: (2009)

4-Nerolidylcatechol: apoptosis by mitochondrial mechanisms with reduction in cyclin D1 at G0/G1 stage of the chronic myelogenous K562 cell line
por: Benfica, Polyana Lopes, et al.
Publicado: (2017)

Kinetics of Internalization and Cytotoxicity of Transferrin‐Neocarzinostatin Conjugate in Human Leukemia Cell Line, K562
por: Kohgo, Yutaka, et al.
Publicado: (1990)

Differential Gene Expression Analysis in K562 Human Leukemia Cell Line Treated with Benzene
por: Choi, Sulji, et al.
Publicado: (2011)

Fangchinoline induces G0/G1 arrest by modulating the expression of CDKN1A and CCND2 in K562 human chronic myelogenous leukemia cells
por: WANG, YUPING, et al.
Publicado: (2013)

Corrigendum to “Usnea Acid as Multidrug Resistance (MDR) Reversing Agent against Human Chronic Myelogenous Leukemia K562/ADR Cells via an ROS Dependent Apoptosis”
por: Wang, Wenjing, et al.
Publicado: (2021)

6,7-Dimethoxycoumarin Influences the Erythroid Differentiation of Human Chronic Myelogenous Leukemia K562 Cells through Regulating FOXO3/p27 Signal Pathway
por: Zheng, Li, et al.
Publicado: (2022)

Platelet Microparticles Protect Acute Myelogenous Leukemia Cells against Daunorubicin-Induced Apoptosis
por: Cacic, Daniel, et al.
Publicado: (2021)

The choice of first-line Chronic Myelogenous Leukemia treatment
por: Fava, Carmen, et al.
Publicado: (2015)

A SOLUBLE‐FACTOR(S) SECRETED BY A HUMAN SKIN CANCER CELL LINE SUPPORTS CLONAL GROWTH OF ADULT T‐CELL LEUKEMIA CELLS
por: Kagami, Yoshitoyo, et al.
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_jdthceo854npdrbj8kferifun3